Company Overview - Shandong Xinhua Medical Equipment Co., Ltd. specializes in the manufacturing and sales of medical devices and pharmaceutical equipment, providing compatible medical services and medical commerce [2] - The company is a leading entity in the Chinese medical device industry, holding several key positions in various associations and has developed innovative products such as the world's first peracetic acid low-temperature sterilizer [2] Financial Performance - For Q1 2025, the company reported revenue of 2.308 billion yuan, a year-on-year decrease of 8.74%, and a net profit of 160 million yuan, down 23.97% compared to the previous year [3] - The company's gross profit margin stood at 23.79% [3] Market Position - As of August 11, the company's stock closed at 18.14 yuan, with a rolling price-to-earnings (PE) ratio of 17.17, marking a new low in 161 days [1] - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Xinhua Medical at the 36th position within the industry [1] Shareholder Information - As of March 31, 2025, the number of shareholders for Xinhua Medical reached 38,959, an increase of 5,308 from the previous count, with an average holding value of 352,800 yuan per shareholder [1]

来源：金融界 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均54.32倍，行业中值38.11倍，新华医疗排 名第33位。 股东方面，截至2025年3月31日，新华医疗股东户数38959户，较上次增加5308户，户均持股市值35.28 万元，户均持股数量2.76万股。 山东新华医疗器械股份有限公司的主营业务是医疗器械、制药装备的制造销售，提供适配的医疗服务与 医疗商贸。公司的主要产品是医疗器械制造产品、制药装备产品、医疗商贸产品、医疗服务。公司是中 国医疗器械行业协会会长单位，中国医学装备协会副理事长单位，感染与控制技术专业委员会理事长单 位，中国放射治疗产业技术创新战略联盟理事长单位，中国制药装备行业协会理事单位，中国医药设备 工程协会理事单位。公司研制开发了全球第一台过氧乙酸低温灭菌器、国内首台高能医用电子直线加速 器等高精尖产品，建成了国内首个智慧化消毒供应中心等行业创新工程，荣获了中国灭菌设备领域第一 张FDA认证证书。公司是国家重点高新技术企业，拥有行业内第一家国家认定企业技术中心，设有"博 士后科研工作站"、"先进医疗设备及器械山东省工程研究中心"等多个省级技术研发平台，每年新增重 点技术创 ...

Core Viewpoint - The article highlights the significant role of Shandong Xinhua Medical Instrument Co., Ltd. in the medical device and pharmaceutical equipment sectors, emphasizing its historical development, technological innovations, and industry leadership. Group 1: Company Overview - Founded in 1943, Xinhua Medical is the first medical device manufacturer established by the Party and the Army, and it went public in 2002, marking the beginning of its rapid growth [2] - The company has evolved into a comprehensive enterprise encompassing four major sectors: medical devices, pharmaceutical equipment, medical commerce, and medical services, establishing a crucial position in the industry [2] Group 2: Technological Innovations - Xinhua Medical recently showcased its new product, the Xinhua Tai'a intelligent circular online adaptive radiotherapy system, at the ESTRO 2025 conference, featuring a groundbreaking circular frame structure and advanced technologies for enhanced treatment efficiency [2] - The company has developed a production management platform for its radiotherapy product division, improving production efficiency through digitalization and real-time data analysis [4] Group 3: Market Position and Product Range - Xinhua Medical boasts nine product lines covering critical areas such as radiotherapy and hospital infection control, with over 14,000 products, making it one of the most comprehensive medical device companies in China [4] - The company has a dominant market share in hospital infection control products, exceeding 70%, and has introduced several innovative products that have received widespread acclaim [5] Group 4: Achievements and Recognition - Xinhua Medical is recognized as the largest manufacturer of radiotherapy equipment in China, having developed the country's first cobalt-60 therapy machine in 1969, and continues to lead in technological advancements [5] - The company has received multiple accolades, including recognition for its XHA600E medical electronic linear accelerator among the top domestic medical equipment products [5] Group 5: Pharmaceutical Equipment Innovations - The pharmaceutical equipment division has made significant strides, introducing the first continuous BFS (Blow-Fill-Seal) equipment in China, achieving a production capacity of 45,000 units per hour [8][10] - Xinhua Medical is the first in China and the second globally to master continuous BFS technology, breaking foreign monopolies and earning numerous patents and certifications [10] Group 6: Future Directions - The company is committed to innovation-driven development, focusing on integrating advanced technologies such as artificial intelligence and big data into its operations, and aims to enhance its global market presence [12][13] - Xinhua Medical is actively pursuing international collaborations and establishing research centers to attract top talent and optimize resource allocation, reinforcing its position as a leader in the medical device industry [12]

Group 1 - The core business of the company includes the manufacturing and sales of medical devices and pharmaceutical equipment, as well as providing medical services and trade [2] - The company is a leading entity in the Chinese medical device industry, holding several key positions in industry associations and has developed innovative products such as the world's first peracetic acid low-temperature sterilizer [2] - As of the first quarter of 2025, the company reported a revenue of 2.308 billion yuan, a year-on-year decrease of 8.74%, and a net profit of 160 million yuan, down 23.97% [3] Group 2 - The company's current rolling price-to-earnings (PE) ratio is 14.22, significantly lower than the industry average of 49.10 and the industry median of 36.43 [1][3] - The total market capitalization of the company is 9.118 billion yuan, ranking it 33rd in the medical device industry based on PE ratio [1] - As of the first quarter of 2025, 11 institutions hold shares in the company, with a total holding of 266.514 million shares valued at 4.283 billion yuan [1]